(Q44361901)
Statements
Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid (English)
Michael Lein
Kurt Miller
Manfred Wirth
Lothar Weissbach
Christoph May
Katja Schmidt
Ulrike Haus